Cargando…
Serum levels of interleukin 6 in patients with lung cancer.
Serum interleukin 6 (IL-6) levels were measured in 75 patients with lung cancer and in 20 patients with benign lung diseases. IL-6 was detectable in 29 patients with lung cancer (39%), but was not detectable in any of the patients with benign lung diseases. Serum C-reactive protein levels and plasma...
Autores principales: | Yanagawa, H., Sone, S., Takahashi, Y., Haku, T., Yano, S., Shinohara, T., Ogura, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033769/ https://www.ncbi.nlm.nih.gov/pubmed/7734307 |
Ejemplares similares
-
Induction by Interleukin‐15 of Human Killer Cell Activity against Lung Cancer Cell Lines and Its Regulatory Mechanisms
por: Takeuchi, Eiji, et al.
Publicado: (1996) -
Comparative analysis of interleukin 15 and interleukin 2 for induction of killer activity and of type 2 cytokine production by mononuclear cells from lung cancer patients.
por: Takeuchi, E., et al.
Publicado: (1998) -
Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995) -
Induction Mechanism of Human Blood CD8(+) T Cell Proliferation and Cytotoxicity by Natural Killer Cell Stimulatory Factor (Interleukin‐12)
por: Nabioullin, Roustem, et al.
Publicado: (1994) -
Interleukin‐2‐inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients
por: Sone, Saburo, et al.
Publicado: (1991)